Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations
出版年份 2013 全文链接
标题
Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations
作者
关键词
Clozapine, Risperidone, Olanzapine, Aripiprazole, Atypical Antipsychotic
出版物
CNS DRUGS
Volume 27, Issue 7, Pages 545-572
出版商
Springer Nature
发表日期
2013-07-02
DOI
10.1007/s40263-013-0079-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Interactions between antiepileptics and second-generation antipsychotics
- (2012) Jose de Leon et al. Expert Opinion on Drug Metabolism & Toxicology
- Emergence of Neuroleptic Malignant Syndrome While Switching Between Risperidone and Paliperidone
- (2012) Po-Ren Teng et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
- (2011) Herbert Y. Meltzer et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of 5-HT2A and 5-HT2C receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats
- (2011) Meaghan Creed-Carson et al. BEHAVIOURAL BRAIN RESEARCH
- Serotonin Receptors of Type 6 (5-HT6): What can we Expect from them?
- (2011) D. Marazziti et al. CURRENT MEDICINAL CHEMISTRY
- 5-HT6 receptor and cognition
- (2011) Xabier Codony et al. CURRENT OPINION IN PHARMACOLOGY
- The role of serotonin receptors in the action of atypical antipsychotic drugs
- (2011) HY Meltzer et al. CURRENT OPINION IN PHARMACOLOGY
- Strain-dependent effects of the histamine H4 receptor antagonist JNJ7777120 in a murine model of acute skin inflammation
- (2011) Gabriella Coruzzi et al. EXPERIMENTAL DERMATOLOGY
- Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis
- (2011) Steven L. Dubovsky et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment
- (2011) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia
- (2011) Robert W. Buchanan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Improvement of Oral Dyskinesia After Switching From Aripiprazole to Paliperidone: A Case Report
- (2011) C.-H. Lai JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Switching from Quetiapine to Ziprasidone
- (2011) Onur N. Karayal et al. Journal of Psychiatric Practice
- Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head–head comparisons
- (2011) Peter M Haddad et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Interactions of recombinant human histamine H1, H2, H3, and H4 receptors with 34 antidepressants and antipsychotics
- (2011) Heidrun Appl et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Serotonergic regulation of neuronal excitability in the prefrontal cortex
- (2011) Rodrigo Andrade NEUROPHARMACOLOGY
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Switching among Antipsychotics in Everyday Clinical Practice: Focus on Ziprasidone
- (2011) Alessandro Rossi et al. POSTGRADUATE MEDICINE
- The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment
- (2011) Herbert Y. Meltzer et al. PSYCHOPHARMACOLOGY
- Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
- (2011) Steven G. Potkin et al. SCHIZOPHRENIA RESEARCH
- Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)
- (2010) S. H. L. Thomas et al. ACTA PSYCHIATRICA SCANDINAVICA
- Benefits of switching women schizophrenic patients to aripiprazole: a case study and brief review of the literature
- (2010) Murat Kuloglu et al. Archives of Womens Mental Health
- The dopamine D4 receptor: biochemical and signalling properties
- (2010) Pieter Rondou et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Predictors of Early Worsening after Switch to Aripiprazole
- (2010) Chi-Un Pae et al. CLINICAL DRUG INVESTIGATION
- Effectiveness of Switching From Aripiprazole to Ziprasidone in Patients With Schizophrenia
- (2010) Sung-Wan Kim et al. CLINICAL NEUROPHARMACOLOGY
- Intramuscular Paliperidone Palmitate
- (2010) Sheridan M. Hoy et al. CNS DRUGS
- Therapeutic Role of 5-HT1A Receptors in The Treatment of Schizophrenia and Parkinson's Disease
- (2010) Yukihiro Ohno CNS Neuroscience & Therapeutics
- Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone
- (2010) Marc De Hert et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
- (2010) C.U. Correll EUROPEAN PSYCHIATRY
- Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion
- (2010) Leslie Citrome Expert Opinion on Drug Metabolism & Toxicology
- Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic
- (2010) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis
- (2010) Paul Fallon et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia
- (2010) S Gopal et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
- (2010) Henry A Nasrallah et al. NEUROPSYCHOPHARMACOLOGY
- Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
- (2010) J. Schoemaker et al. PHARMACOPSYCHIATRY
- Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders
- (2010) Saki Shimizu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Switching from conventional antipsychotics to ziprasidone: A randomized, open-label comparison of regimen strategies
- (2010) Emmanuel Stip et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: A case series
- (2010) Cheng-Yuan Chen et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Presynaptic control of serotonin on striatal dopamine function
- (2010) Sylvia Navailles et al. PSYCHOPHARMACOLOGY
- Clozapine-Withdrawal Catatonia
- (2010) M. Wadekar et al. PSYCHOSOMATICS
- Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
- (2009) Douglas E Faries et al. BMC Psychiatry
- Effectiveness of Switching to Aripiprazole From Atypical Antipsychotics in Patients With Schizophrenia
- (2009) Sung-Wan Kim et al. CLINICAL NEUROPHARMACOLOGY
- Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia
- (2009) S. Gopal et al. CURRENT MEDICAL RESEARCH AND OPINION
- Getting specialized: presynaptic and postsynaptic dopamine D2 receptors
- (2009) Claudia De Mei et al. CURRENT OPINION IN PHARMACOLOGY
- Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study
- (2009) Chi-Un Pae et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Lurasidone: a new drug in development for schizophrenia
- (2009) Jonathan M Meyer et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia
- (2009) Sung-Wan Kim et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety
- (2009) Chris Hawley et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia
- (2009) Hans-Jürgen Möller et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study
- (2009) Diego Novick et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study
- (2009) Koksal Alptekin et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder
- (2009) Chang Yoon Kim et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic
- (2009) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Adjunctive α2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission
- (2009) Monica M. Marcus et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study
- (2009) Michelle Kramer et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Lurasidone in the Treatment of Acute Schizophrenia
- (2009) Mitsutaka Nakamura et al. JOURNAL OF CLINICAL PSYCHIATRY
- Reduction in Neuroleptic-Induced Movement Disorders After a Switch to Quetiapine in Patients With Schizophrenia
- (2009) Leonardo Cortese et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Improved Body Weight and Metabolic Outcomes in Overweight or Obese Psychiatric Patients Switched to Amisulpride From Other Atypical Antipsychotics
- (2009) Chao-Cheng Lin et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Hyperdopaminergic Tone Erodes Prefrontal Long-Term Potential via a D2 Receptor-Operated Protein Phosphatase Gate
- (2009) T.-X. Xu et al. JOURNAL OF NEUROSCIENCE
- Effects of Tandospirone, a 5-HT1A Agonistic Anxiolytic Agent, on Haloperidol-Induced Catalepsy and Forebrain Fos Expression in Mice
- (2009) Yukihiro Ohno et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Aripiprazole in Treatment-refractory Schizophrenia
- (2009) Wen-Yu Hsu et al. Journal of Psychiatric Practice
- Combined treatment with quetiapine and sertindole in therapy refractory insomnia after clozapine discontinuation
- (2009) F Hanisch et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Therapeutic potential of α2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders
- (2009) Junta Imaki et al. NEUROSCIENCE LETTERS
- H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats
- (2009) Gin C. Hsieh et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Switching to Aripiprazole in Outpatients with Schizophrenia Experiencing Insufficient Efficacy and/or Safety/Tolerability Issues with Risperidone: A Randomized, Multicentre, Open-label Study
- (2009) V. Ryckmans et al. PHARMACOPSYCHIATRY
- Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved
- (2009) Arne Mørk et al. PSYCHOPHARMACOLOGY
- Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
- (2009) Atheir I. Abbas et al. PSYCHOPHARMACOLOGY
- The 5-HT7 receptor and disorders of the nervous system: an overview
- (2009) Peter B. Hedlund PSYCHOPHARMACOLOGY
- Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
- (2009) David Hough et al. SCHIZOPHRENIA RESEARCH
- Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?
- (2008) Herbert Y. Meltzer et al. BEHAVIOURAL BRAIN RESEARCH
- Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
- (2008) Rohan Ganguli et al. BMC Medicine
- Commentary on strategies for switching antipsychotics
- (2008) John M Davis et al. BMC Medicine
- Metabolism of Atypical Antipsychotics: Involvement of Cytochrome P450 Enzymes and Relevance for Drug-Drug Interactions
- (2008) Liana Urichuk et al. CURRENT DRUG METABOLISM
- Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia
- (2008) S. Ganesan et al. CURRENT MEDICAL RESEARCH AND OPINION
- Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia
- (2008) Douglas E. Faries et al. CURRENT MEDICAL RESEARCH AND OPINION
- Upcoming Agents for the Treatment of Schizophrenia
- (2008) Delia Bishara et al. DRUGS
- Proposed strategies for successful clinical management with aripiprazole
- (2008) Rajnish Mago EXPERT OPINION ON PHARMACOTHERAPY
- Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone
- (2008) Alessandro Rossi et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- A Randomized, Open-Label Comparison of 2 Switching Strategies to Aripiprazole Treatment in Patients With Schizophrenia
- (2008) Hiroyoshi Takeuchi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Four-Week, Double-Blind, Placebo- and Ziprasidone-Controlled Trial of Iloperidone in Patients With Acute Exacerbations of Schizophrenia
- (2008) Andrew J. Cutler et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Long-Term Efficacy and Safety of Iloperidone
- (2008) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Safety Profile of Iloperidone
- (2008) Peter J. Weiden et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Efficacy of Iloperidone in the Treatment of Schizophrenia
- (2008) Steven G. Potkin et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?
- (2008) Elizabeth Scarr et al. JOURNAL OF NEUROCHEMISTRY
- Loss of Muscarinic Autoreceptor Function Impairs Long-Term Depression But Not Long-Term Potentiation in the Striatum
- (2008) P. Bonsi et al. JOURNAL OF NEUROSCIENCE
- Use of Aripiprazole in treatment resistant schizophrenia
- (2008) D. Hughes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Change in sexual dysfunction with aripiprazole: a switching or add-on study
- (2008) Amna Mir et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Asenapine: a novel psychopharmacologic agent with a unique human receptor signature
- (2008) M. Shahid et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pharmacological Analysis of the Novel, Rapid, and Potent Inactivation of the Human 5-Hydroxytryptamine7 Receptor by Risperidone, 9-OH-Risperidone, and Other Inactivating Antagonists
- (2008) J. A. Knight et al. MOLECULAR PHARMACOLOGY
- Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens
- (2008) Yukihiro Ohno et al. NEUROPHARMACOLOGY
- Synthesis, trafficking, and localization of muscarinic acetylcholine receptors
- (2008) Neil M. Nathanson PHARMACOLOGY & THERAPEUTICS
- Evaluation of the antibradykinetic actions of 5-HT1A agonists using the mouse pole test
- (2008) Yukihiro Ohno et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole
- (2008) Mong-Liang Lu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: A double-blind randomized placebo-controlled study
- (2008) Shahin Akhondzadeh et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Atypical Antipsychotics: CATIE Study, Drug-Induced Movement Disorder and Resulting Iatrogenic Psychiatric-Like Symptoms, Supersensitivity Rebound Psychosis and Withdrawal Discontinuation Syndromes
- (2008) Guy Chouinard et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Does switching to a new antipsychotic improve outcomes?
- (2008) Robert A Rosenheck et al. SCHIZOPHRENIA RESEARCH
- Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: Analysis of a randomized, open-label study
- (2008) Matthew J. Byerly et al. SCHIZOPHRENIA RESEARCH
- Muscarinic acetylcholine receptors as CNS drug targets
- (2007) Christopher J. Langmead et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation